Language: English
Current: English
- English
- 中文
- 日本語
- Español
Region: Americas
Current Americas

Become a member
Cart (0)
Sign in

Already a DIA Member? Sign in. Not a member? Join.

Keep me logged in

Forgot User ID? or Forgot Password?

Create Account and Join Register

Menu Back toAgenda

Canada Annual Meeting

The Canada Annual Meeting now includes a track for Pharmacovigilance and Risk Management Strategies!

Agenda

Day 1 Oct 11, 2022

9:00 AM — 12:30 PM Short Course: Global Advertising and Promotion – Considerations for Compliance and Success

Day 2 Oct 18, 2022

7:00 AM — 5:00 PM Meeting Registration
7:00 AM — 8:00 AM Networking Breakfast
8:00 AM — 8:10 AM Opening Remarks
8:10 AM — 9:10 AM Plenary Session: The Future of Clinical Information Flow: Breaking the Document Paradigm
9:15 AM — 10:15 AM Session 1: Whatever Happened to the Regulatory Review of Drugs and Devices (R2D2) – 2017-2021?
10:15 AM — 10:45 AM Refreshment and Networking Break
10:45 AM — 12:00 PM Session 2: Understanding Health Canada’s Regulatory Modernization Plans: Agile Licensing for Drugs
12:00 PM — 1:15 PM Networking Luncheon
1:15 PM — 2:30 PM Session 3: The What and How of Transparency of Clinical Trial Information
2:30 PM — 3:00 PM Refreshment and Networking Break
3:00 PM — 4:15 PM Session 4: Transforming Clinical Trial Design
4:20 PM — 5:20 PM Session 5: Regulatory Innovation for Health Products: Agile Licensing for Medical Devices
5:20 PM — 6:20 PM Networking Reception

Day 3 Oct 19, 2022

7:00 AM — 3:10 PM Meeting Registration
7:00 AM — 8:00 AM Networking Breakfast
8:00 AM — 9:15 AM Session 6, Track C: Monitoring Post-Market Compliance through GVP Inspections and Proactive Risk Management Projects
8:00 AM — 9:15 AM Session 6, Tracks A, B: Real-World Data (RWD) and Real-World Evidence (RWE) in Regulatory Decision Making
9:20 AM — 10:35 AM Session 7 Track A, C: Use of Artificial Intelligence in Pharmacovigilance (PV)
9:20 AM — 10:35 AM Session 7, Tracks B, C: Key Considerations for Successful Risk Minimization
10:35 AM — 11:05 AM Refreshment and Networking Break
11:05 AM — 12:20 PM Session 8, Track C: Vanessa's Law: Impact and Challenges of Mandatory Adverse Reaction Reporting
11:05 AM — 12:20 PM Session 8, Tracks A, B: Innovation and Collaboration in Oncology
12:20 PM — 1:35 PM Networking Luncheon
1:35 PM — 2:55 PM Plenary Session: Patient Engagement throughout the Product Life Cycle
2:55 PM — 3:10 PM Closing Remarks
3:10 PM — 3:10 PM Meeting Adjourns

Contact us

Registration Questions?

Send Email
+1.215.442.6100

PRECONFERENCE SHORT COURSES

Global Advertising and Promotion – Considerations for Compliance and Success

Additional Information

Live Meeting Policies

Download the DIA App

Discover DIA’s Live In-Person

Canada Annual Meeting Resource Kit